New anticoagulants and antiplatelet agents: a primer for the clinical gastroenterologist.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24402526.
- Also identified by DOI 10.1038/ajg.2013.228.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The discovery of the first oral anticoagulant, warfarin, was a milestone in anticoagulation. Warfarin's well-known limitations, however, have led to the recent development of more effective anticoagulants. The rapidly growing list of these drugs, however, presents a challenge to endoscopists who must treat patients on these sundry medications. This review is intended to summarize the pharmacological highlights of new anticoagulants, with particular attention to suggested "best-practice" recommendations for the withholding of these drugs before endoscopic procedures.
Medical subject headings
- Anticoagulants
- Blood Loss, Surgical
- Endoscopy
- Thromboembolism